Refractory Status Epilepticus and Therapeutic Uncertainties: a Comprehensive Review on Targeting Neuroinflammation and Rationale for Developing a Platform Trial
Shanika Samarasekera(University Hospitals Birmingham NHS Foundation Trust), Tonny Veenith(New Cross Hospital), Vikram Patil(University of Wolverhampton), C. Chacko(University of Wolverhampton), Randeep Mullhi(University Hospitals Birmingham NHS Foundation Trust), Suresh Renukappa(University of Wolverhampton), Ruoling Chen(University of Wolverhampton), Zubair Ahmed(University of Birmingham), William J. Scotton(New Cross Hospital), Asha Patel(Parul University), Suneesh Thilak(New Cross Hospital), Prashant Nasa(The Royal Wolverhampton NHS Trust)
Cited by 0
Related Papers
Diagnosis and management of subarachnoid haemorrhage
|Nature Communications|2024|154
The Role of Caspase-2 in Regulating Cell Fate
|Cells|2020|76
QbD-steered development and validation of an RP-HPLC method for quantification of ferulic acid: Rational application of chemometric tools
|Journal of Chromatography B|2020|61
Pharmacological Inhibition of Caspase-2 Protects Axotomised Retinal Ganglion Cells from Apoptosis in Adult Rats
|PLoS ONE|2012|49
Association of air pollution with dementia: a systematic review with meta-analysis including new cohort data from China
|Environmental Research|2022|45